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The relationship between protein glycosylation and fatty acylation of glycoproteins was studied in the wild-type and as- 
paragine-linked glycosylation-deficient mutants (algl and alg2) of Saccharomyces revisiae. At the non-permissive tem- 
perature (37°C), both mutant cells exhibited increased incorporation of [aH]palmitate into five polypeptides based on 
SDS-PAGE. In contrast, the wild-type yeast cells contained pH]palmitate-labeled polypeptides of higher molecular 
weights, which were converted to the bands een in the mutant cells upon treatment of the cell extract with endoglycosid- 
ase H prior to SDS-PAGE. In addition, labeling of the wild-type yeast cells with [aH]palmitate in the presence of tuniea- 
mycin revealed the incorporation of pH]paimitate into the same five bands as found in the algl and alg2 mutants at 
the non-permissive temperature without unieamycin. These results indicate that fatty acylation of glycoproteins proceeds 
independently of protein N-glycosylation i yeast cells. 
Fatty acylated protein; Glycoprotein 
1. INTRODUCTION 
Glycosylation and fatty acylation represent co- 
translational orpost-translational modifications of
soluble or membrane proteins. Fatty acids are at- 
tached to proteins in eukaryotes by an amide 
linkage (myristate) to the amino-terminal glycine, 
by an O- or thio-ester linkage (palmitate) to 
serine/threonine or cysteine residues, respectively, 
or as part of a glycophospholipid.attached to the 
carboxy-terminal amino acid of the membrane pro- 
teins [1-3]. The functions of fatty acylation of pro- 
teins are largely unknown. A role for the acylation, 
deacylation and reacylation in protein transport 
has been suggested [4], and recent studies have 
revealed that the N-myristoyl transferase activity is 
essential for vegetative growth of yeast cells [5]. 
Previous tudies of the effect of inhibition of N- 
glycosylation on palmitoylation of glycoproteins 
have yielded different results depending on the 
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nature of the proteins under study. Tunicamycin, 
an inhibitor of N-linked glycosylation [6], also in- 
hibits the palmitoylation f viral glycoprotein and 
its transport to the cell surface [7]. On the other 
hand, tunicamycin does not affect he palmitoyla- 
tion of the transferrin receptor or its transport to 
the cell surface [8]. We have previously reported 
that the perturbation of the N-linked oligosac- 
charide structure results in an altered incorporation 
of [3H]palmitate into specific proteins in Chinese 
hamster ovary cells [9]. In the present study, we 
have examined the effect of a mutational defect in 
N-glycosylation  palmitoylation f glycoproteins 
in yeast cells using defined mutants deficient in the 
glycosylation pathway. 
2. MATERIALS AND METHODS 
Wild-type yeast (Saccharomyces cerevisiae) strain DBY 640 
and two asparagine-linked glycosylation-deficient mutants (algl 
and alg2) were used in the present study, algl mutant cells are 
expected to contain glycoproteins substituted with 
GlcNAc2-Asn, while alg2 mutant cells should contain 
Manl-2GlcNAc2-Asn-substituted glycoproteins [10]. YPD 
medium (1 07o yeast extract, 2070 bactopeptone, and 2°70 glucose) 
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was used for the growth of yeast cells. [3H]Palmitic acid (20 
Ci/mmol), [35S]methionine (800 Ci/mmol) and 'ENHANCE' 
for fluorography were purchased from New England Nuclear. 
Molecular weight standards were purchased from Sigma 
Chemical Co. Endoglycosidase H was obtained from 
Boehringer-Mannheim Biochemicals. 
2.1. Labeling experiment 
Yeast cells at A6oonm of 2.5 were grown for 4 h to mid- 
exponential phase at 26°C, and half of the culture was shifted 
to 37°C. 30 min later, 4 ml samples of each culture was labeled 
with either [3H]palmitate (20/zCi/ml) or [35S]methionine (100 
izCi/ml). For labeling in the presence of tunicamycin, the drug 
was added to a final concentration f5 izg/ml, 15 rain prior to 
the addition of radioactive precursors. Labeling was continued 
for 4 h, and the cells were collected by centrifugation, and wash- 
ed three times with ice-cold 10 mM NAN3. Cells were resuspend- 
ed in 100 mM Tris-HC1 buffer (pH 6.8) containing 10 mM 
phenylmethylsulfonyl fluoride, 2070 SDS and 10070 glycerol, and 
disrupted with the aid of glass beads (401zm) first by vortex mix- 
ing and then in a Branson bath sonicator. Finally, the solubiliz- 
ed sample was incubated at 95°C for 3 min. 
2.2. Gel electrophoresis and fluorography 
SDS-polyacrylamide g l electrophoresis was performed in 
1307o gel according to Laemmli [11], but in the absence of 
2-mercaptoethanol since thio-ester-linked fatty acids might be 
labile to the sulfhydryl reagent [12]. Molecular weight standards 
used in SDS-PAGE included myosin (200000),/?-galactosidase 
(166000), phosphorylase b (97400), bovine serum albumin 
(66200), ovalbumin (42700), ricin B chain (35000), ricin A 
chain (30 000), soybean trypsin inhibitor (21 500) and myoglobin 
(16 900). Fluorography was used for gels containing 
[3H]palmitate-labeled proteins, and the 'ENHANCE'-treated 
gels were exposed to Kodak XAR-5 film (8 inch x 11 inch). Gels 
containing [35S]methionine-labeled samples were fixed and ex- 
posed for 24 h before developing. 
2.3. Endoglycosidase H treatment 
[3H]Palmitate-labeled samples solubilized in SDS as describ- 
ed above were mixed with an equal volume of 0.3 M Na citrate 
buffer (pH 5.5), and endoglycosidase H was added to a final 
concentration f4/zg (100 mU) per ml. Following a 20 h incuba- 
tion at 37°C, proteins were precipitated with the addition of 4 
vols of ice-cold acetone, and collected by centrifugation. The 
pellets were dried under a stream of N2, and resuspended in the 
solubilizing buffer before electrophoresis. 
3. RESULTS 
N-linked glycosylation-deficient mutants algl 
and aig2 cells labeled with [3H]palmitate at 37°C 
were found to contain several fatty acylated 
polypeptides not seen in the wild-type cells labeled 
under the same condition; proteins with apparent 
molecular weights of  158000, 136000, 41000, 
30000 and 15 300, respectively, appeared to be pro- 
minently labeled with [3H]palmitate, and to a lesser 
extent, two additional proteins with apparent 
molecular weights of  27 500 and 26 000 were noted 
(fig. 1A). In contrast, the wild-type cells contained 
[3H]palmitate-labeled polypeptides with apparent 
molecular weights of  > 200 000, 51 000, 31 000 and 
27000, respectively. The different profiles of  
[3H]palmitate-labeled proteins between the wild- 
type strain and algl/alg2 mutants were not seen 
when [35S]methionine-labeled proteins were 
analyzed with SDS-PAGE (fig.lB). Thus the dif- 
ferent labeling patterns with [3H]palmitate between 
the wild-type and the mutant cells do not reflect 
differences in the metabolic conversion of  
palmitate into amino acids, nor do they result f rom 
an increased synthesis of  a subset of  proteins in the 
mutant cells as compared to the wild-type cells. In- 
tense labeling of  high molecular weight proteins 
(>200000)  with [3H]palmitate was not accom- 
panied by a concomitant increase in the labeling 
with [35S]methionine, Thus the polypeptides readi- 
ly labeled with [3H]palmitate represent fatty 
acylated proteins. Those [3H]palmitate-labeled 
proteins unique to the algl and alg2 mutants may 
represent increased fatty acylation of  proteins due 
to defective N-glycosylation, as shown previously 
in CHO cell mutants [9]. Alternatively, these pro- 
teins are both fatty acylated and glycosylated, and 
the apparent differences in the molecular weight 
distribution of  fatty acylated proteins between the 
wild-type and the mutants result f rom the loss of  
N-l inked oligosaccharides f rom the glycoproteins. 
Two approaches were taken to ascertain the lat- 
ter possibility. Treatment with endoglycosidase H 
was used to remove N-linked oligosaccharide 
chains f rom [3H]palmitate-labeled glycoproteins. 
As shown in fig.2A, treatment of  [aH]palmitate- 
labeled proteins from the wild-type cells led to the 
appearance of four [3H]palmitate-labeled polypep- 
tides with apparent molecular weight of  169000, 
46000, 38000, and 16600, respectively. These 
polypeptides might correspond to all but one of  the 
[3H]palmitate-labeled polypeptides seen in algl 
and alg2 mutants (fig. 1A). The minor bands unaf- 
fected by endoglycosidase H treatment may be 
non-glycosylated proteins. 
The effect of  tunicamycin on the labeling pattern 
of  [3H]palmitate in the wild-type cells was studied. 
As shown in fig.2B, five [3H]palmitate-labeled 
polypeptides were observed with apparent 
molecular weights of  151000, 126000, 43000, 
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Fig. 1. SDS-gel electrophoresis of fatty acylated proteins from 
the wild-type and mutant yeast cells. Crude extracts from cells 
labeled with [3H]palmitate (panel A) or with [35S]methionine 
(panel B) at 37°C were examined by SDS-gel electrophoresis. 
(A) [3HlPalmitate-labeled c llextracts. Lane 1, wild-type yeast 
cells, strain DBY 640 (150/~g, 3 x 106 dpm); lane 2, algl mutant 
cells (150/~g, 5 x 106 dpm); lane 3, alg2 mutant cells (150/~g, 
5 x 106 dpm). (B) [35S]Methionine-labeled cell extracts from the 
wild-type DBY 640 (lane 1), algl mutant (lane 2) and alg2 
mutant (lane 3). For [3H]palmitate-labeled samples (panel A), 
fluorography with 'ENHANCE' was used, and the gels were 
exposed to Kodak XAR-5 film for 14 days at -70°C before 
developing. Gels containing [35S]methionine-labeled samples 
were fixed and exposed to Kodak XAR-5 film for 24 h at - 70°C 
before developing. 
37000 and 16600, respectively. These five fatty 
acylated polypeptides corresponded very well in 
apparent molecular weights with those seen in algl 
and alg2 mutants labeled at the non-permissive 
temperature in the absence of tunicamycin. 
Significantly, the relative intensities of 
[3H]palmitate-labeled polypeptides in tunicamycin- 
treated wild-type ceils and those following en- 
doglycosidase H treatment of [3H]palmitate- 
labeled wild-type cells are similar to those seen in 
algl and alg2 mutant cells. These results taken 
together strongly suggest hat these palmitate- 
labeled polypeptides are also N-glycosylated, and 
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Fig.2. Effects of tunicamycin or endoglycosidase H treatment 
on the apparent mobilities of fatty acylated proteins from wild- 
type yeast cell extract. Crude cellular extracts from wild-type 
DBY 640 yeast cells labeled at 37°C with [3H]palmitate were 
examined by SDS-gel electrophoresis. (A) Lanes: 1, untreated 
sample containing 1.2 x 106 dpm; 2, endoglycosidase H-treated 
sample containing 1.2 x 106 dpm. (B) Wild-type yeast cells 
labeled with [3H]palmitate in the absence (lane 1) or presence 
(lane 2) of tunicamycin (5/~g/ml). 180/~g labeled proteins were 
applied to each lane. 
the difference in [3H]palmitate-labeling profiles 
between the wild-type and mutant cells is due to a 
reduction in apparent molecular weights of these 
fatty acylated glycoproteins a a consequence of a 
shortening of the N-linked oligosaccharide chains. 
The observations that the high molecular weight 
(> 200 000) palmitate-labeled polypeptides in the 
wild-type cells disappeared following en- 
doglycosidase H treatment or when the labeling 
was done in the presence of tunicamycin support 
this conclusion. 
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4. DISCUSSION 
Glycosylation and fatty acylation are covalent 
modifications of proteins which are biochemically 
distinct processes. A temporal and/or  topological 
coincidence, if not interdependence, may exist be- 
tween these two processes as suggested by several 
recent observations. Thus results of pulse-chase ex- 
periments indicate that palmitoylation of proteins 
takes place in the Golgi region where many of the 
maturation steps in glycosylation pathway also oc- 
cur [13]. Acyl transferase activity was found to be 
enriched in Golgi-rich microsomal fractions [14]. 
Many glycoproteins and fatty acylated proteins 
also appear to share a common subcellular destina- 
tion, e.g. the plasma membrane. 
Previous studies have suggested an unexpected 
relationship between fatty acylation of glycopro- 
teins and its intracellular trafficking through the 
secretory pathway. Increased incorporation of 
[3H]palmitate into yeast glycoproteins was observ- 
ed in yeast mutants defective in an early step of 
protein secretion [15]. We have reported that CHO 
mutants deficient in N-glycosylation contained in- 
creased palmitoylation of membrane glycoproteins 
[9]. These results suggest hat glycoproteins with 
altered N-linked oligosaccharide structures may be 
over-acylated due to either conformational changes 
in the proteins or an increased exposure to the acy- 
lating enzymes as a result of defective intracellular 
transport. 
In the present study, we have employed yeast 
cells to investigate the relationship between a defec- 
tive N-glycosylation and fatty acylation of pro- 
teins. Our results show that all the major 
palmitoylated proteins in algl and alg2 mutants 
can be generated in the wild-type cells if the label- 
ing is performed in the presence of tunicamycin. 
Likewise, they can be produced by endoglycosidase 
H treatment of wild-type cells labeled with 
palmitate in the absence of tunicamycin. Abolition 
of N-glycosylation does not result in an increase in 
fatty acylation of proteins otherwise unmodified in 
the wild-type cells under conditions of unperturbed 
glycosylation. Thus it would appear that in yeast 
cells, glycosylation is not a prerequisite for proteins 
to enter the compartment where fatty acylation 
takes place, nor does the presence or absence of 
glycosylation affect the extent of fatty acylation. 
This conclusion is consistent with the observation 
of Slomiani et al. that acylation of rat gastric 
mucus glycoproteins occurs at the protease- 
susceptible non-glycosylated region of the polypep- 
tide, away from the protease-resistant glycosyla- 
tion sites [14]. 
The change in apparent molecular weights of 
almost all of the palmitate-labeled proteins follow- 
ing endoglycosidase H treatment or with labeling 
carried out in the presence of tunicamycin indicates 
that palmitoylation i yeast cells is limited largely 
to glycoproteins. This selective palmitoylation of 
glycoproteins may be merely a reflection of a com- 
mon subcellular localization of two distinct and in- 
dependent modification reactions. Yeast cells may 
differ in this respect from other eukaryotic ells in 
which many palmitoylated proteins are not 
glycoproteins [3]. 
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